The changing landscape of therapeutic therapy demands a re-evaluation of established approaches. Modern research is altering focus towards individualized treatment regimens, incorporating genomics, proteomics, and other sophisticated biomarkers to anticipate subject response and lessen adverse consequences. This developing paradigm emphasizes preci